Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 10  •  04:00PM ET
104.75
Dollar change
+1.93
Percentage change
1.88
%
IndexS&P 500 P/E50.71 EPS (ttm)2.07 Insider Own0.45% Shs Outstand113.38M Perf Week3.58%
Market Cap11.88B Forward P/E17.52 EPS next Y5.98 Insider Trans-8.02% Shs Float112.86M Perf Month0.31%
Enterprise Value14.32B PEG1.96 EPS next Q1.03 Inst Own103.08% Short Float6.26% Perf Quarter15.39%
Income239.21M P/S4.16 EPS this Y6.75% Inst Trans-1.17% Short Ratio4.72 Perf Half Y22.09%
Sales2.86B P/B1.62 EPS next Y10.70% ROA1.95% Short Interest7.06M Perf YTD8.27%
Book/sh64.68 P/C12.91 EPS next 5Y8.94% ROE3.21% 52W High120.39 -12.99% Perf Year-8.79%
Cash/sh8.11 P/FCF23.37 EPS past 3/5Y-22.97% -20.54% ROIC2.38% 52W Low81.36 28.75% Perf 3Y-22.82%
Dividend Est.0.28 (0.27%) EV/EBITDA17.89 Sales past 3/5Y-4.82% -5.47% Gross Margin46.74% Volatility3.69% 4.10% Perf 5Y-28.85%
Dividend TTM0.28 (0.27%) EV/Sales5.02 EPS Y/Y TTM-18.80% Oper. Margin13.84% ATR (14)4.10 Perf 10Y138.12%
Dividend Ex-DateApr 17, 2026 Quick Ratio1.40 Sales Y/Y TTM3.67% Profit Margin8.38% RSI (14)48.06 Recom2.32
Dividend Gr. 3/5Y0.00% 0.00% Current Ratio1.68 EPS Q/Q8.45% SMA20-4.38% Beta1.09 Target Price117.88
Payout13.61% Debt/Eq0.46 Sales Q/Q5.85% SMA500.79% Rel Volume0.86 Prev Close102.82
Employees11000 LT Debt/Eq0.38 EarningsFeb 02 BMO SMA2009.84% Avg Volume1.50M Price104.75
IPOJul 06, 1965 Option/ShortYes / Yes EPS/Sales Surpr.8.29% 0.93% Trades Volume1,282,338 Change1.88%
Date Action Analyst Rating Change Price Target Change
Dec-15-25Downgrade BofA Securities Buy → Neutral $110
Dec-09-25Initiated Goldman Neutral $105
Oct-16-25Initiated Guggenheim Neutral
May-01-25Upgrade UBS Neutral → Buy $115
Jan-10-25Downgrade Bernstein Outperform → Mkt Perform $130
Dec-13-24Upgrade BofA Securities Neutral → Buy $138
Oct-15-24Upgrade Barclays Equal Weight → Overweight $125 → $140
Aug-28-24Initiated Wells Fargo Equal Weight $130
Jul-08-24Initiated Leerink Partners Outperform $125
Jun-03-24Resumed Jefferies Hold $115
Feb-05-26 07:45PM
08:00AM
Feb-03-26 09:50AM
Feb-02-26 02:01PM
12:52PM
12:44PM Loading…
12:44PM
10:28AM
10:06AM
09:49AM
09:30AM
07:15AM
06:29AM
06:21AM
06:00AM
Jan-31-26 10:01PM
12:51PM Loading…
Jan-29-26 12:51PM
Jan-28-26 09:15AM
07:10AM
Jan-26-26 04:05PM
10:00AM
Jan-23-26 12:10PM
Jan-21-26 07:58AM
Jan-14-26 06:07AM
Jan-13-26 06:43PM
04:35PM
11:17AM
10:14AM
09:42AM
05:51AM
05:28AM
04:15PM Loading…
Jan-12-26 04:15PM
08:57AM
Jan-09-26 08:00AM
Jan-05-26 04:51AM
Dec-31-25 07:39AM
Dec-22-25 10:37PM
Dec-19-25 08:41AM
Dec-18-25 08:00AM
Dec-17-25 11:04PM
Dec-16-25 08:00AM
Dec-15-25 06:30AM
Dec-09-25 08:16AM
Nov-26-25 11:30AM
Nov-19-25 08:35AM
Nov-10-25 07:45AM
Nov-03-25 12:31AM
Oct-28-25 08:00AM
06:17AM
01:31AM
Oct-27-25 03:00PM
01:22PM
01:10PM
10:05AM
09:30AM
07:10AM
06:18AM
06:09AM
06:00AM
Oct-25-25 11:02PM
Oct-23-25 04:05PM
07:53AM
Oct-22-25 09:15AM
Oct-21-25 10:00AM
Oct-20-25 10:00AM
Oct-16-25 02:40AM
Oct-14-25 11:35PM
08:00AM
Oct-13-25 11:38AM
Oct-09-25 11:55AM
Oct-06-25 08:00AM
Oct-02-25 08:00AM
Sep-29-25 08:00AM
Sep-23-25 02:26PM
Sep-22-25 08:00AM
Sep-12-25 12:35AM
Sep-10-25 04:53AM
Sep-03-25 12:36PM
Sep-02-25 02:26PM
08:00AM
Aug-27-25 04:32PM
Aug-18-25 08:00AM
12:02AM
Aug-13-25 12:23AM
12:21AM
Aug-12-25 02:20PM
Aug-06-25 08:00AM
Jul-30-25 09:25AM
Jul-29-25 03:02AM
Jul-28-25 02:15PM
11:51AM
11:51AM
10:11AM
09:30AM
07:39AM
07:10AM
06:26AM
06:07AM
06:00AM
Jul-26-25 11:04PM
Jul-25-25 12:10PM
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh Prahlad R.Please See RemarksFeb 05 '26Option Exercise92.0925,5252,350,597145,738Feb 06 04:05 PM
Singh Prahlad R.Please See RemarksFeb 05 '26Sale100.2125,5252,557,859120,213Feb 06 04:05 PM
Goldberg Joel SPlease See RemarksFeb 05 '26Option Exercise92.0912,7171,171,10955,964Feb 06 04:05 PM
Goldberg Joel SPlease See RemarksFeb 05 '26Sale100.2112,7171,274,35743,247Feb 06 04:05 PM
Singh Prahlad R.OfficerFeb 05 '26Proposed Sale100.2125,5252,557,886Feb 05 04:35 PM
Goldberg Joel SOfficerFeb 05 '26Proposed Sale100.2112,7171,274,382Feb 05 04:12 PM
Vohra Tajinder SPlease See RemarksFeb 02 '26Option Exercise92.095,756530,07016,198Feb 04 04:05 PM
Vohra Tajinder SPlease See RemarksFeb 02 '26Sale104.505,756601,50210,442Feb 04 04:05 PM
Vohra Tajinder SOfficerFeb 02 '26Proposed Sale104.505,756601,502Feb 02 10:57 AM
MICHAS ALEXIS PDirectorAug 27 '25Sale89.0150044,5057,270Aug 28 04:05 PM
MICHAS ALEXIS POfficerAug 27 '25Proposed Sale88.0050044,000Aug 27 03:29 PM
McMurry-Heath MichelleDirectorMay 29 '25Sale92.1760055,2994,833May 30 04:06 PM
McMurry-Heath MichelleDirectorMay 29 '25Proposed Sale92.1760055,299May 29 02:23 PM
Last Close
Feb 10  •  04:00PM ET
53.98
Dollar change
+1.24
Percentage change
2.35
%
BWA BorgWarner Inc daily Stock Chart
Index- P/E86.49 EPS (ttm)0.62 Insider Own0.95% Shs Outstand216.39M Perf Week11.14%
Market Cap11.55B Forward P/E10.50 EPS next Y5.14 Insider Trans-3.73% Shs Float211.89M Perf Month13.24%
Enterprise Value13.60B PEG1.09 EPS next Q1.19 Inst Own101.43% Short Float5.48% Perf Quarter20.14%
Income134.00M P/S0.81 EPS this Y9.92% Inst Trans-9.41% Short Ratio3.98 Perf Half Y40.24%
Sales14.18B P/B1.95 EPS next Y8.28% ROA0.92% Short Interest11.61M Perf YTD19.80%
Book/sh27.68 P/C5.32 EPS next 5Y9.59% ROE2.24% 52W High53.00 1.85% Perf Year83.98%
Cash/sh10.15 P/FCF9.31 EPS past 3/5Y-12.47% -16.06% ROIC1.34% 52W Low24.40 121.23% Perf 3Y27.00%
Dividend Est.0.60 (1.10%) EV/EBITDA6.67 Sales past 3/5Y-1.72% 6.72% Gross Margin18.50% Volatility2.90% 2.25% Perf 5Y40.46%
Dividend TTM0.56 (1.04%) EV/Sales0.96 EPS Y/Y TTM-83.69% Oper. Margin9.23% ATR (14)1.20 Perf 10Y102.20%
Dividend Ex-DateMar 02, 2026 Quick Ratio1.69 Sales Y/Y TTM0.08% Profit Margin0.94% RSI (14)76.47 Recom2.31
Dividend Gr. 3/5Y-13.51% -8.34% Current Ratio2.05 EPS Q/Q-29.98% SMA2010.19% Beta1.07 Target Price51.42
Payout29.26% Debt/Eq0.68 Sales Q/Q4.12% SMA5015.76% Rel Volume1.66 Prev Close52.74
Employees38300 LT Debt/Eq0.67 EarningsFeb 11 BMO SMA20032.94% Avg Volume2.91M Price53.98
IPOAug 13, 1993 Option/ShortYes / Yes EPS/Sales Surpr.5.04% -1.19% Trades Volume4,773,188 Change2.35%
Date Action Analyst Rating Change Price Target Change
Jan-08-26Downgrade Piper Sandler Overweight → Neutral $51
Sep-10-25Downgrade BofA Securities Buy → Neutral $46
Sep-03-25Upgrade Robert W. Baird Neutral → Outperform $52
Apr-10-25Upgrade Goldman Neutral → Buy $34
Apr-10-25Downgrade UBS Buy → Neutral $38 → $31
Mar-18-25Upgrade Exane BNP Paribas Neutral → Outperform $36
Mar-07-25Downgrade TD Cowen Buy → Hold $31
Sep-10-24Resumed Deutsche Bank Hold $36
Sep-05-24Resumed Wolfe Research Peer Perform
Mar-15-24Initiated Piper Sandler Overweight $43
Today 07:11AM
06:48AM
06:30AM
06:30AM
Feb-10-26 09:15AM
10:00AM Loading…
Feb-06-26 10:00AM
Feb-05-26 05:55PM
06:30AM
Feb-04-26 05:50PM
10:00AM
Jan-30-26 09:56AM
07:12AM
Jan-29-26 11:34AM
08:43AM
Jan-28-26 09:40AM
01:35AM Loading…
Jan-26-26 01:35AM
Jan-23-26 11:16AM
09:50AM
09:30AM
Jan-22-26 10:11AM
Jan-14-26 12:10PM
Jan-12-26 09:50AM
09:40AM
Jan-09-26 06:19PM
12:27PM
Jan-08-26 11:40AM
Jan-06-26 09:15AM
Jan-05-26 08:10PM
Jan-02-26 03:27PM
04:32AM
07:33AM Loading…
Dec-31-25 07:33AM
Dec-26-25 09:40AM
Dec-23-25 09:58AM
Dec-22-25 11:40AM
11:30AM
Dec-17-25 09:50AM
Dec-16-25 09:40AM
09:40AM
Dec-05-25 05:49PM
Dec-03-25 09:40AM
Nov-26-25 09:50AM
Nov-20-25 09:00AM
08:04AM
Nov-17-25 09:41AM
Nov-13-25 06:30AM
Nov-07-25 09:50AM
Nov-04-25 09:00AM
Oct-31-25 09:40AM
Oct-30-25 09:02PM
02:11PM
11:05AM
09:30AM
08:01AM
08:00AM
08:00AM
08:00AM
08:00AM
07:40AM
06:40AM
06:30AM
Oct-28-25 08:40AM
Oct-24-25 10:00AM
Oct-23-25 10:00AM
Oct-22-25 09:50AM
Oct-21-25 10:30AM
Oct-16-25 10:47AM
09:45AM
Oct-15-25 11:25AM
09:40AM
Oct-14-25 11:19AM
10:44AM
Oct-13-25 12:10PM
Oct-10-25 08:24AM
Oct-06-25 09:50AM
Oct-01-25 10:35AM
Sep-29-25 04:21PM
09:45AM
Sep-26-25 09:40AM
Sep-15-25 10:02AM
09:40AM
09:40AM
08:27AM
05:37AM
Sep-12-25 09:50AM
Sep-11-25 09:45AM
Sep-10-25 11:02AM
09:51AM
09:40AM
Sep-09-25 11:16AM
08:30AM
Sep-07-25 10:08AM
Sep-03-25 08:33AM
Sep-02-25 05:37AM
Aug-29-25 02:00PM
Aug-27-25 02:30AM
12:22AM
Aug-25-25 09:45AM
Aug-22-25 09:40AM
Aug-21-25 09:50AM
Aug-18-25 04:05AM
BorgWarner, Inc. engages in the provision of technology solutions for combustion, hybrid and electric vehicles. It operates through the following segments: Air Management, Drivetrain & Battery Systems, and ePropulsion. The Air Management segment includes technologies, such as turbochargers, eBoosters, eTurbos, timing systems, emissions systems, thermal systems, gasoline ignition technology, smart remote actuators, powertrain sensors, cabin heaters, battery heaters, battery charging, and direct current charging stations. The Drivetrain & Battery Systems segment consists of battery modules and systems, control modules, friction and mechanical clutch products for automatic transmissions, torque-management products and rear-wheel drive (RWD), and all-wheel drive (AWD) transfer case systems and coupling systems. The ePropulsion segment focuses on power electronics, such as inverters, onboard chargers, DC/DC converters, and combination boxes. The company was founded in 1928 and is headquartered in Auburn Hills, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Demmerle StefanVice PresidentNov 11 '25Sale45.5215,000682,750209,040Nov 13 12:34 PM
Demmerle StefanVice PresidentNov 12 '25Sale46.005,000230,000204,040Nov 13 12:34 PM
Demmerle StefanOfficerNov 12 '25Proposed Sale45.6420,000912,750Nov 12 04:47 PM
McKenzie IsabelleVice PresidentNov 04 '25Sale44.233,200141,55243,555Nov 05 03:10 PM
McKenzie IsabelleOfficerNov 04 '25Proposed Sale44.233,200141,552Nov 04 04:13 PM
McKenzie IsabelleVice PresidentSep 11 '25Sale44.183,500154,63246,755Sep 12 02:49 PM
McKenzie IsabelleOfficerSep 11 '25Proposed Sale44.183,500154,632Sep 11 05:01 PM
Weng VolkerVice PresidentSep 05 '25Sale43.9710,000439,70768,008Sep 08 03:10 PM
Demmerle StefanVice PresidentSep 05 '25Sale44.005,000220,006224,040Sep 08 03:10 PM
Demmerle StefanOfficerSep 05 '25Proposed Sale44.005,000220,006Sep 05 04:29 PM
Weng VolkerOfficerSep 05 '25Proposed Sale43.9710,000439,707Sep 05 04:16 PM
McKenzie IsabelleVice PresidentSep 04 '25Sale43.453,000130,35050,255Sep 05 02:48 PM
McKenzie IsabelleOfficerSep 04 '25Proposed Sale43.453,000130,350Sep 04 04:21 PM
MICHAS ALEXIS PDirectorSep 02 '25Sale42.318,772371,18478,903Sep 03 05:09 PM
MICHAS ALEXIS PDirectorSep 02 '25Proposed Sale42.318,772371,184Sep 02 04:03 PM
McKenzie IsabelleVice PresidentAug 28 '25Sale42.932,690115,47053,255Aug 29 03:23 PM
McKenzie IsabelleOfficerAug 28 '25Proposed Sale42.932,690115,470Aug 28 04:05 PM
McKenzie IsabelleVice PresidentAug 12 '25Sale40.012,500100,02555,945Aug 14 04:40 PM
Demmerle StefanVice PresidentAug 12 '25Sale39.3115,000589,718234,040Aug 14 04:39 PM
Demmerle StefanVice PresidentAug 13 '25Sale40.505,000202,500229,040Aug 14 04:39 PM
Demmerle StefanOfficerAug 13 '25Proposed Sale40.505,000202,500Aug 13 05:22 PM
Demmerle StefanOfficerAug 12 '25Proposed Sale39.3115,000589,718Aug 12 05:00 PM
McKenzie IsabelleOfficerAug 12 '25Proposed Sale40.012,500100,025Aug 12 04:53 PM
Aaron CraigEVP & CFOAug 04 '25Sale37.6621,000790,94049,801Aug 06 02:55 PM
McKenzie IsabelleVice PresidentAug 04 '25Sale37.715,000188,55058,445Aug 06 02:54 PM
Farrell Paul ArthurEVP & Chief Strategy OfficerAug 04 '25Sale37.6311,416429,60238,768Aug 06 02:53 PM
Demmerle StefanVice PresidentAug 04 '25Sale38.1720,000763,384249,040Aug 06 02:53 PM
Demmerle StefanOfficerAug 04 '25Proposed Sale38.1720,000763,383Aug 04 04:12 PM
Farrell Paul ArthurOfficerAug 04 '25Proposed Sale37.6311,416429,602Aug 04 04:07 PM
McKenzie IsabelleOfficerAug 04 '25Proposed Sale37.715,000188,550Aug 04 04:05 PM
Aaron CraigOfficerAug 04 '25Proposed Sale37.6621,000790,939Aug 04 04:04 PM
McKenzie IsabelleVice PresidentMay 16 '25Sale33.255,000166,25063,445May 20 10:27 AM
McKenzie IsabelleOfficerMay 16 '25Proposed Sale33.255,000166,250May 16 05:52 PM
Weng VolkerVice PresidentMay 12 '25Sale32.9810,000329,80078,008May 13 02:43 PM
CALAWAY TONIT MEVP, CAO, Gen Counsel & SecMay 12 '25Sale32.8327,736910,581214,521May 13 02:43 PM
Weng VolkerOfficerMay 12 '25Proposed Sale32.9810,000329,800May 13 10:01 AM
CALAWAY TONIT MOfficerMay 12 '25Proposed Sale32.8327,736910,581May 12 04:32 PM
Weng VolkerVice PresidentMay 09 '25Sale31.5415,978503,97888,008May 12 01:18 PM
Weng VolkerOfficerMay 09 '25Proposed Sale31.5415,978503,978May 09 04:09 PM
Weng VolkerVice PresidentMar 10 '25Sale30.299,764295,752103,986Mar 12 12:36 PM
CALAWAY TONIT MEVP, CAO, Gen Counsel & SecMar 10 '25Sale30.078,300249,582242,257Mar 12 12:36 PM
CALAWAY TONIT MOfficerMar 10 '25Proposed Sale30.078,300249,582Mar 10 05:19 PM
Weng VolkerOfficerMar 10 '25Proposed Sale30.299,764295,752Mar 10 04:12 PM
Wingfield TaniaEVP & CHROMar 05 '25Sale28.7924,000690,93839,110Mar 06 04:50 PM
Wingfield TaniaOfficerMar 05 '25Proposed Sale28.7924,000690,938Mar 05 04:09 PM
Weng VolkerVice PresidentFeb 26 '25Sale30.497,053215,047121,002Feb 27 04:25 PM
Weng VolkerOfficerFeb 26 '25Proposed Sale30.497,053215,047Feb 26 04:41 PM